Artiva Biotherapeutics, Inc. ARTV Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artiva Biotherapeutics, Inc.'s deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artiva Biotherapeutics, Inc.'s deferred tax assets and other non-current assets?
- Artiva Biotherapeutics, Inc. (ARTV) reported deferred tax assets and other non-current assets of $458K in Q1 2026.
- How has Artiva Biotherapeutics, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
- Artiva Biotherapeutics, Inc.'s deferred tax assets and other non-current assets increased by 3423.1% year-over-year, from $13K to $458K.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s deferred tax assets and other non-current assets?
- Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s deferred tax assets and other non-current assets has grown at a 8.1% compound annual growth rate (CAGR), from $392K to $458K.